Impact of a clinical pathway on treatment outcome in patients with acute pancreatitis

Table 1 Aetiology of acute pancreatitis: Comparison of the two periods n (%)

Aetiology	Period 2006-2007	Period 2010-2012	χ2test	P value
Unexplained	52 (46.8)	16 (11.5)	47.21	0.000
Alcohol	27 (24.3)	54 (38.8)
Gallstones	23 (20.7)	54 (38.8)
Drug-induced	5 (4.5)	4 (2.9)
Pancreas divisum	2 (1.8)	0 (0)
Post-ERCP	2 (1.8)	4 (2.9)
Cancer	0 (0)	3 (2.2)
Hyperlipemic	0 (0)	4 (2.9)
All	111 (100.0)	139 (100.0)

¹Fischer’s test. ERCP: Endoscopic retrograde cholangiopancreatography.

Table 2 Use of antibiotic therapy and treatment outcome: Comparison of the two periods n (%)

	Period	Period	χ2test	P value
	2006-2007	2010-2012
Patients with prescribed antibiotics	78 (70.3)	72 (51.8)	8.7741	0.003
Mortality	2 (1.8)	4 (2.9)	0.3051	0.581

¹Fischer’s test.